- 6 days & nights inpatient stay
- 6 follow up visits
Participants are reimbursed for their time and this clinical trial has been approved by an independent ethics committee.
About the study
This study is looking at developing a treatment medication for obesity management and Type-2 diabetes. This new drug mimics the actions of a hormone called GLP-1 (glucagon-like peptide 1) that is naturally produced in the body. GLP-1 is produced in the intestine and brain and primarily serves to control blood sugar levels, appetite and stomach emptying. The new drug is very similar in structure to normal human GLP-1 and so may have similar effects in your body. Participants in this
study will receive a single dose of this medication and then return to the centre for follow up appointments.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at firstname.lastname@example.org quoting “Body Weight Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!